The Centers for Medicare & Medicaid Services announced Sept. 28 that it projects declines in average premiums for Medicare Advantage and Part D in 2027. Weighted average MA premiums are expected to decline 16.5% from $14.37 in 2026 to $12.00 in 2027. The total average monthly Part D premium for standalone prescription drug plans is estimated to increase by less than $1, from $35.09 in 2026 to $36 in 2027. Following application of MA rebates, average Part D premiums for MA plans with prescription drug coverage are projected to decrease 38%, from $11.32 in 2026 to $7 in 2027.

CMS is also projecting MA enrollment to be 34 million in 2027, approximately 47% of all Medicare enrollees. Access to MA plans will remain stable in 2027, with more than 99% of Medicare beneficiaries having access to at least one plan and 97% of beneficiaries having access to 10 or more MA plan choices. 

Headline
The Centers for Medicare & Medicaid Services announced Sept. 18 that all 50 states, Washington, D.C., and Puerto Rico have applied to participate in its…
Headline
The U.S. District Court for the Eastern District of Pennsylvania Aug. 5 granted a motion for the AHA and the Hospital and Healthsystem Association of…
Headline
The Centers for Medicare & Medicaid Services July 27 released its Contract Year 2025 Part C and Part D Program Audit and Enforcement Report, outlining key…
Blog
Public
Medicare Advantage now covers more than half of eligible Medicare beneficiaries, making its impact on hospitals, health systems and patients impossible to…
Headline
The Food and Drug Administration June 22 announced multiple actions to help accelerate early- and late-stage drug development. The actions are part of a larger…
Headline
The Medicare Payment Advisory Commission June 15 released its June report to Congress that estimated the association between Medicare Advantage enrollment and…